A comparative study of Vo2 max among passive smokers and smokeless tobacco users in Northern Gujarat
Bioinformation · 31.10.2026 · 22 (10) · 6809-6814
DOI: 10.6026/973206300226809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Gnanadesigan Ekambaram.
Abstract (Originalsprache)
Maximal oxygen consumption (VO2 max) is regarded as the benchmark for muscular and cardiovascular fitness. Therefore, it is of interest to evaluate the effects on VO2 max among tobacco users and passive smokers. In India, tobacco is used in a wide range of smokeless forms and chewing is done in a variety of ways. Exposure to passive smoking is linked with various health effects in non-smoking individuals. This study comprised two groups with 100 male subjects. Anthropometric measurements and test parameters (VO2 Max) were done as per the standard procedures. The study found that VO2 max values were significantly reduced in passive smokers (P value 0.0036). In passive smokers, BMI showed a moderate inverse correlation with VO₂ max (r = -0.490). A negative correlation was observed between BSA and VO₂ max (r = -0.501), and it was statistically significant (p < 0.001) in passive smokers. Thus, data shows that VO2 max was significantly decreased in passive smokers compared to smokeless tobacco users (SLT).
Zitieren
APA
Ekambaram, G. (2026). A comparative study of Vo2 max among passive smokers and smokeless tobacco users in Northern Gujarat. Bioinformation, 22(10), 6809-6814. https://doi.org/10.6026/973206300226809
Vancouver
Ekambaram G. A comparative study of Vo2 max among passive smokers and smokeless tobacco users in Northern Gujarat. Bioinformation. 2026;22(10):6809-6814. doi:10.6026/973206300226809
BibTeX
@article{Ekambaram2026,
author = {Ekambaram, Gnanadesigan},
title = {A comparative study of Vo2 max among passive smokers and smokeless tobacco users in Northern Gujarat},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {6809--6814},
doi = {10.6026/973206300226809}
}
EUVIMED